Abstract
Background and Aims
Inflammatory bowel disease (IBD) has many characteristics of autoimmune diseases. Sensorineural hearing loss has been reported in many autoimmune diseases. Little is known about hearing loss in patients with IBD.
Methods
A prospective blinded comparative study was conducted over a 3-year period. IBD patients and controls underwent a complete otorhinolaryngeal examination and eudiometry test.
Results
Altogether 105 participants (76 patients and 29 controls) took part in this study. Mean age was 36, 51 % were males, and 40 % of the patients were presently hospitalized due to IBD exacerbation. Audiometric examination revealed that any hearing loss (mild to severe) was found in 29 (38 %) of the IBD population, compared to 4 (14 %) of the control group (p = 0.02). Extraintestinal manifestation (EIM) was present in 33/76 (43 %) of IBD patients. Any hearing loss and moderate to severe hearing loss were found in 17/33 (52 %) and 7/33 (21 %) in the EIM-positive group compared to 12/43 (28 %) and 4/43 (9 %) in the EIM-negative group (p = 0.036 and p = 0.14, respectively). Out of patients over the age of 40 with other EIMs, all 11/11 (100 %) of patients had any hearing loss compared to 8/12 (66 %) of patients over the age of 40 without other EIMs, p = 0.035.
Conclusions
Hearing loss may be another EIM of IBD. It is found in 38 % of IBD patients and in up to 52 % of patients with other EIMs and increases over the age of 40. Early hearing evaluation should be recommended to these high-risk IBD patients.
Similar content being viewed by others
References
Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46–54 e42; quiz e30.
Xu XR, Liu CQ, Feng BS, Liu ZJ. Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease. World J Gastroenterol. 2014;20:3255–3264.
Shih DQ, Targan SR. Insights into IBD pathogenesis. Curr Gastroenterol Rep. 2009;11:473–480.
Geremia A, Biancheri P, Allan P, Corazza GR, Di Sabatino A. Innate and adaptive immunity in inflammatory bowel disease. Autoimmun Rev. 2014;13:3–10.
Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2001;96:1116–1122.
Hopkins DJ, Horan E, Burton IL, Clamp SE, de Dombal FT, Goligher JC. Ocular disorders in a series of 332 patients with Crohn’s disease. Br J Ophthalmol. 1974;58:732–737.
Mir-Madjlessi SH, Taylor JS, Farmer RG. Clinical course and evolution of erythema nodosum and pyoderma gangrenosum in chronic ulcerative colitis: a study of 42 patients. Am J Gastroenterol. 1985;80:615–620.
Rasmussen HH, Fallingborg J, Mortensen PB, et al. Primary sclerosing cholangitis in patients with ulcerative colitis. Scand J Gastroenterol. 1992;27:732–736.
Bernstein CN, Blanchard JF, Leslie W, Wajda A, Yu BN. The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann Intern Med. 2000;133:795–799.
Purrmann J, Zeidler H, Bertrams J, et al. HLA antigens in ankylosing spondylitis associated with Crohn’s disease. Increased frequency of the HLA phenotype B27, B44. J Rheumatol. 1988;15:1658–1661.
Bernstein CN, Blanchard JF, Houston DS, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost. 2001;85:430–434.
Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn’s disease and ulcerative colitis: a study of 700 patients. Medicine (Baltim). 1976;55:401–412.
Lidar M, Carmel E, Kronenberg Y, Langevitz P. Hearing loss as the presenting feature of systemic vasculitis. Ann N Y Acad Sci. 2007;1107:136–141.
Abbasi M, Yazdi Z, Kazemifar AM, Bakhsh ZZ. Hearing loss in patients with systemic lupus erythematosus. Glob J Health Sci. 2013;5:102–106.
Lin C, Lin SW, Weng SF, Lin YS. Risk of sudden sensorineural hearing loss in patients with systemic lupus erythematosus: a population-based cohort study. Audiol Neurootol. 2013;18:95–100.
Smith KA, Yunker WK. Kawasaki disease is associated with sensorineural hearing loss: a systematic review. Int J Pediatr Otorhinolaryngol. 2014;78:1216–1220.
Bakthavachalam S, Driver MS, Cox C, Spiegel JH, Grundfast KM, Merkel PA. Hearing loss in Wegener’s granulomatosis. Otol Neurotol. 2004;25:833–837.
Magaro M, Zoli A, Altomonte L, et al. Sensorineural hearing loss in rheumatoid arthritis. Clin Exp Rheumatol. 1990;8:487–490.
Vavricka SR, Greuter T, Scharl M, et al. Cogan’s syndrome in patients with inflammatory bowel disease—a case series. J Crohn’s Colitis. 2015;9:886–890.
Ruckenstein MJ. Autoimmune inner ear disease. Curr Opin Otolaryngol Head Neck Surg. 2004;12:426–430.
Yazici S, Benbir G, Ince B. Sensorineural hearing loss and status epilepticus associated with ulcerative colitis: is there enough evidence to support immune-related mechanisms? J Neurosci Rural Pract. 2015;6:77–79.
Nemoto H, Iguchi H, Ichikawa Y, Wakata N, Kurihara T. Ulcerative colitis presenting as sensorineural deafness, brainstem encephalopathy, and white matter lesions. Neurologist. 2004;10:165–168.
Kanra G, Kara A, Secmeer G, et al. Sensorineural hearing loss as an extra-intestinal manifestation of ulcerative colitis in an adolescent girl with pyoderma gangrenosum. Eur J Pediatr. 2002;161:216–218.
Kumar BN, Walsh RM, Wilson PS, Carlin WV. Sensorineural hearing loss and ulcerative colitis. J Laryngol Otol. 1997;111:277–278.
Jacob A, Ledingham JG, Kerr AI, Ford MJ. Ulcerative colitis and giant cell arteritis associated with sensorineural deafness. J Laryngol Otol. 1990;104:889–890.
Bachmeyer C, Leclerc-Landgraf N, Laurette F, et al. Acute autoimmune sensorineural hearing loss associated with Crohn’s disease. Am J Gastroenterol. 1998;93:2565–2567.
Summers RW, Harker L. Ulcerative colitis and sensorineural hearing loss: is there a relationship? J Clin Gastroenterol. 1982;4:251–252.
Hollanders D. Sensorineural deafness—a new complication of ulcerative colitis? Postgrad Med J. 1986;62:753–755.
Dowd A, Rees WD. Treatment of sensorineural deafness associated with ulcerative colitis. Br Med J (Clin Res Ed). 1987;295:26.
Weber RS, Jenkins HA, Coker NJ. Sensorineural hearing loss associated with ulcerative colitis. A case report. Arch Otolaryngol. 1984;110:810–812.
Kariya S, Fukushima K, Kataoka Y, Tominaga S, Nishizaki K. Inner-ear obliteration in ulcerative colitis patients with sensorineural hearing loss. J Laryngol Otol. 2008;122:871–874.
Staecker H, Lefebvre P. Autoimmune sensorineural hearing loss improved by tumor necrosis factor-alpha blockade: a case report. Acta Otolaryngol. 2002;122:684–687.
Akbayir N, Calis AB, Alkim C, et al. Sensorineural hearing loss in patients with inflammatory bowel disease: a subclinical extraintestinal manifestation. Dig Dis Sci. 2005;50:1938–1945.
Kalyoncu D, Urganci N, Calis AB, Ozbal A. Sensorineural hearing loss in pediatric patients with inflammatory bowel disease. Dig Dis Sci. 2010;55:150–152.
Karmody CS, Valdez TA, Desai U, Blevins NH. Sensorineural hearing loss in patients with inflammatory bowel disease. Am J Otolaryngol. 2009;30:166–170.
Casella G, Corbetta D, Zolezzi M, et al. Symptomatic sensorineural hearing loss in patients with ulcerative colitis. Tech Coloproctol. 2015;19:729–731.
Goodall AF, Siddiq MA. Current understanding of the pathogenesis of autoimmune inner ear disease: a review. Clin Otolaryngol. 2015;40:412–419.
Vavricka SR, Brun L, Ballabeni P, et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol. 2011;106:110–119.
Henry JA, Dennis KC, Schechter MA. General review of tinnitus: prevalence, mechanisms, effects, and management. J Speech Lang Hear Res. 2005;48:1204–1235.
Neuhauser HK, von Brevern M, Radtke A, et al. Epidemiology of vestibular vertigo: a neurotologic survey of the general population. Neurology. 2005;65:898–904.
Author contributions
Dr. Dov Wengrower was the principal investigator and study initiator and was responsible for the patient recruitment as well as data collection and analysis. Dr. Benjamin Koslowsky was responsible for writing the manuscript, collecting the data, performing the statistics, and helped recruit patients for the study. Dr. Uri Peleg was responsible for performing the hearing examinations and collecting data on the hearing test results in Shaare-Zedek Medical Center. Mrs. Betty Mazuz was responsible for patient coordination, explanations, and completion of the study in Shaare-Zedek Medical Center. Dr. Leore Cohen was responsible for data collection and analyzing the data throughout the study. Dr. Menahem Gross was responsible for performing the hearing examinations and collecting data on the hearing test results in Hadassah Medical Center. Prof. Eran Goldin was responsible for patient recruitment and study supervision. Dr. Chanan Shaul was the principal otolaryngologist in the study and performed interpretation and data collection and supervision of the study. Mrs. Chana Jacobson is thanked for collaborating our study.
Funding
This work was funded by the Mirsky Foundation in Shaare-Zedek Medical Center, Jerusalem, Israel
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
There was no conflict of interest by any of the authors.
Additional information
Dov Wengrower and Benjamin Koslowsky contributed equally to this study.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wengrower, D., Koslowsky, B., Peleg, U. et al. Hearing Loss in Patients with Inflammatory Bowel Disease. Dig Dis Sci 61, 2027–2032 (2016). https://doi.org/10.1007/s10620-016-4074-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-016-4074-9